Pathogenesis, laboratory, and clinical characteristics of helicobacter pylori-associated immune thrombocytopenic purpura

Advances in Clinical Chemistry

Volumn 52, Issue C, 2010, Pages 131-144

  Franchini, Massimo ^a   Plebani, Mario ^b   Montagnana, Martina ^c   Veneri, Dino ^c   Lippi, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Bleeding; Eradication therapy; H. pylori; Thrombocytopenia

Indexed keywords

BOOK; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; THROMBOCYTOPENIC PURPURA;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PURPURA, THROMBOCYTOPENIC;

EID: 77957007689     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(10)52005-5     Document Type: Book

References (60)

1. Suerbaum S., Michetti P. Helicobacter pylori infection. N. Engl. J. Med. 2002, 347:1175-1186.
2. Parsonnet J., Hansen S., Rodriguez I., Gelb A.B., Warnke R.A., Jellum E., et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 1994, 330:1267-1271.
3. Tsang K.W., Lam S.K. Helicobacter pylori and extra-digestive diseases. J. Gastroenterol. Hepatol. 1999, 14:844-850.
4. De Luis D.A., Varela C., de la Calle H. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J. Clin. Gastroenterol. 1998, 26:259-263.
5. Pellicano R., Franceschi F., Saracco G., Fagoonee S., Roccarina D., Gasbarrini A. Helicobacter and extragastric diseases. Helicobacter 2009, 14(Suppl.1):58-68.
6. Franchini M., Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura. Haematologica 2003, 88:1087-1091.
7. Franchini M., Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 2004, 9:342-346.
8. Stasi R., Provan D. Helicobacter pylori and chronic ITP. Hematol. Am. Soc. Hematol. Educ. Program 2008, 206-211.
9. Cover T.L., Blaser M.J. Helicobacter pylori in health and disease. Gastroenterology 2009, 136:1863-1873.
10. Plebani M., Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin. Chim. Acta 2007, 381:39-49.
11. McColl K.E. Clinical practice. Helicobacter pylori infection. N. Engl. J. Med. 2010, 362:1597-1604.
12. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 56:772-781.
13. Zambon C.F., Basso D., Navaglia F., Mazza S., Razetti M., Fogar P., et al. Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting?. Clin. Biochem. 2004, 37:261-267.
14. Ricci C., Holton J., Vaira D. Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract. Res. Clin. Gastroenterol. 2007, 21:299-313.
15. Talley N.J., Vakil N. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am. J. Gastroenterol. 2005, 100:2324-2337.
16. Di Mario F., Cavallaro L.G., Moussa A.M., Caruana P., Merli R., Maini A., et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig. Dis. Sci. 2006, 51:1791-1795.
17. Rugge M., Correa P., Di Mario F., El-Omar E., Fiocca R., Geboes K., et al. OLGA staging for gastritis: a tutorial. Dig. Liver Dis. 2008, 40:650-658.
18. Plebani M., Basso D., Cassaro M., Brigato L., Scrigner M., Toma A., et al. Helicobacter pylori serology in patients with chronic gastritis. Am. J. Gastroenterol. 1996, 91:954-958.
19. Pérez-Paramo M., Albillos A., Calleja J.L., Salas C., Marín M.C., Marcos M.L., et al. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy. Dig. Dis. Sci. 1997, 42:1734-1740.
20. Guariso G., Basso D., Bortoluzzi C.F., Meneghel A., Schiavon S., Fogar P., et al. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children. Clin. Chim. Acta 2009, 402:54-60.
21. Douglas B.C., Blanchette V.S. Immune thrombocytopenic purpura. N. Engl. J. Med. 2002, 436:995-1008.
22. Bettaieb A., Fromont P., Louache F., Oksenhendler E., Vainchenker W., Duédari N., et al. Presence of crossreactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992, 80:162-169.
23. Bettaieb A., Oksenhendler E., Duedari N., Bierling P. Crossreactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin. Exp. Immunol. 1996, 103:19-23.
24. Takahashi T., Yujiri T., Shinohara K., Inoue Y., Sato Y., Fujii Y., et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 2004, 124:91-96.
25. Michel M., Khellfar M., Desforges L., Lee K., Schaeffer A., Godeau B., et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch. Intern. Med. 2002, 162:1033-1036.
26. Franceschi F., Christodoulides N., Kroll M.H., Genta R.M. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann. Int. Med. 2004, 140:766-767.
27. Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998, 352:878.
28. Kohda K., Kuga T., Kogawa K., Kanisawa Y., Koike K., Kuroiwa G., et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br. J. Haematol. 2002, 118:584-588.
29. Gerhard M., Rad R., Prinz C., Naumann M. Pathogenesis of Helicobacter pylori infection. Helicobacter 2002, 7(Suppl. 1):17-23.
30. Veneri D., Gottardi M., Guizzardi E., Zanuso C., Krampera M., Franchini M. Idiopathic thrombocytopenic purpura, Helicobacter pylori infection and HLA class II alleles. Blood 2002, 100:1926-1927.
31. Veneri D., de Matteis G., Solero P., Federici F., Zanuso C., Guizzardi E., et al. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets 2005, 16:307-311.
32. Byrne M.F., Kerrogan S.W., Corcoran P.A., Atherton J.C., Murray F.E., Fitzgerald D.J., et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003, 38:1023-1030.
33. Emilia G., Luppi M., Torelli G. Infectious agents and human immune diseases: lessons from Helicobacter pylori. Am. J. Med. 2005, 118:420-421.
34. Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., et al. Helicobacter pylori eradication shifts monocyte Fcγ receptor balance toward inhibitory FcγRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 2008, 118:2677-2681.
35. Ando T., Tsuzuki T., Mizuno T., Minami M., Ina K., Kusugami K., et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004, 9:443-452.
36. Akiyama H., Onozawa Y. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura. Am. J. Hematol. 1998, 57:91-92.
37. Stasi R., Willis F., Shannon M.S., Gordon-Smith E.C. Infectious causes of chronic immune thrombocytopenia. Hematol. Oncol. Clin. North Am. 2009, 23:1275-1297.
38. Veneri D., Franchini M., Gottardi M., D'Adda M., Ambrosetti A., Krampera M., et al. Efficacy of Helicobacter pylori eradication in enhancing platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002, 87:1777-1779.
39. Fujimura K., Kuwana M., Kurata Y., Imamura M., Harada H., Sakamaki H., et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int. J. Hematol. 2005, 81:162-168.
40. Kodama M., Kitadai Y., Ito M., Kai H., Masuda H., Tanaka S., et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007, 12:36-42.
41. Stasi R., Rossi Z., Stipa E., Amadori S., Newland A.C., Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am. J. Med. 2005, 118:414-419.
42. Suzuki T., Matsushima M., Masui A., Watanabe K., Takagi A., Ogawa Y., et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am. J. Gastroenterol. 2005, 100:1265-1270.
43. Scandellari R., Allemand E., Vettore S., Plebani M., Randi M.L., Fabris F. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. Blood Coagul. Fibrinolysis 2009, 20:108-113.
44. Asahi N., Kuwana M., Suzuki H., Hibi T., Kawakami Y., Ikeda Y. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica 2006, 91:1436-1437.
45. Hino M., Yamane T., Park K., Takubo T., Ohta K., Kitagawa S., et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann. Hematol. 2003, 82:30-32.
46. Hashino S., Mori A., Suzuki S., Izumiyama K., Kahata K., Yonezumi M., et al. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int. J. Hematol. 2003, 77:188-191.
47. Ando K., Shimamoto T., Tauchi T., Ito Y., Kuryiama Y., Gotoh A. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and literature review. Int. J. Hematol. 2003, 77:239-244.
48. Sato R., Murakami K., Watanabe K., Okimoto T., Miyajima H., Ogata M., et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch. Intern. Med. 2004, 164:1904-1907.
49. Nomura S., Inami N., Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur. J. Haematol. 2004, 72:304-305.
50. Inaba T., Mizuno M., Take S., Suwaki K., Honda T., Kawai K., et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur. J. Clin. Invest. 2005, 35:214-219.
51. Emilia G., Longo G., Luppi M., et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001, 97:812-814.
52. Suvajdzic N., Suvajdzić N., Stanković B., Artiko V., Cvejić T., Bulat V., et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets 2006, 17:227-230.
53. Jackson S.C., Beck P., Buret A.G., O'Connor P.M., Meddings J., Pineo G., et al. Long-term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int. J. Hematol. 2008, 88:212-218.
54. Jarque I., Andreu R., Llopis I., et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 2001, 115:1002-1003.
55. Michel M., Cooper N., Jean C., Frissora C., Bussel J.B. Does Helicobacter pylori initiate or perpetuate immune throbocytopenic purpura?. Blood 2004, 103:890-896.
56. Takahashi T., Yujiri T., Tanizawa Y. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood 2004, 104:594.
57. Franchini M., Cruciani M., Mengoli C., Pizzolo G., Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J. Antimicrob. Chemother. 2007, 60:237-246.
58. Arnold D.M., Bernotas A., Nazi I., Stasi R., Kuwana M., Liu Y., et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 2009, 94:850-856.
59. Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009, 113:1231-1240.
60. Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.